UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

Find insight on Novo Nordisk Foundation, ResMed, Johnson & Johnson, and more in the latest Market Talks covering Health Care.

Equities research analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Novo Nordisk ...

Novo Nordisk has faced several challenges recently ... Guggenheim Securities held a Buy rating and raised the price target slightly. UBS upgraded the company's stock from a Sell to a Buy rating ...

UBS upgraded the company's stock from a Sell to a Buy rating, while Bernstein revised its rating from 'Underperform' to 'Market Perform'. These evaluations follow recent developments, including the ...